Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

11.85 -0.21 (-1.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,146,097
Open 12.01
Bid (Size) 11.50 (200)
Ask (Size) 12.30 (10,000)
Prev. Close 12.06
Today's Range 11.83 - 12.11
52wk Range 6.685 - 15.42
Shares Outstanding 1,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal (NASDAQ:AMRX) and its peers. The g... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Reasons to Avoid AMRX and 1 Stock to Buy Instead
Amneal’s 34% return over the past six months has outpaced the S&P 500 by 30.9%, and its stock price has climbed to $13.16 per share. This performance may hav... 
Via StockStory
Topics Stocks

Performance

YTD
-6.4%
-6.4%
1 Month
-18.7%
-18.7%
3 Month
-8.5%
-8.5%
6 Month
+21.5%
+21.5%
1 Year
+43.4%
+43.4%

More News

Read More
News headline image
3 Value Stocks We’re Skeptical Of
Via StockStory
News headline image
Amneal to Participate in Upcoming Investor Conference
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
Amneal Pharmaceuticals Inc (NASDAQ:AMRX) Reports Q4 2025 Earnings Beat on Strong Profitability ↗
Via Chartmill
Topics Earnings
News headline image
Why Amneal (AMRX) Stock Is Trading Lower Today
Via StockStory
News headline image
Amneal (AMRX) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Amneal (NASDAQ:AMRX) Beats Q4 CY2025 Sales Expectations
Via StockStory
News headline image
Amneal Reports Fourth Quarter and Full Year 2025 Financial Results
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
News headline image
Supreme Court Strikes Down IEEPA Tariffs, Mandating Billions in Immediate Rebates
Via MarketMinute
Topics Bonds Economy Government
News headline image
3 Russell 2000 Stocks We Find Risky
Via StockStory
News headline image
3 Small-Cap Stocks That Fall Short
Via StockStory
News headline image
3 Cash-Producing Stocks That Concern Us
Via StockStory
News headline image
3 Healthcare Stocks We Steer Clear Of
Via StockStory
Topics Stocks
News headline image
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
2 Reasons to Sell AMRX and 1 Stock to Buy Instead
Via StockStory
News headline image
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
1 Small-Cap Stock to Target This Week and 2 That Underwhelm
Via StockStory
News headline image
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
3 Healthcare Stocks We’re Skeptical Of
Via StockStory
Topics Stocks
News headline image
Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal to Participate in Upcoming Investor Conferences
From Amneal Pharmaceuticals LLC
Via GlobeNewswire

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 11.85
When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 03/27/26 04:00 PM ET
What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 11.85K
How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Amneal Pharmaceuticals, Inc. - Class A Common Stock has 12K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.